rs762798018
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP5
The NM_001350776.1(MSTO1):c.-266G>A variant causes a 5 prime UTR premature start codon gain change. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001350776.1 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 7AN: 150766Hom.: 0 Cov.: 27 FAILED QC
GnomAD3 exomes AF: 0.000202 AC: 25AN: 123620Hom.: 0 AF XY: 0.000257 AC XY: 17AN XY: 66222
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000219 AC: 152AN: 695628Hom.: 0 Cov.: 9 AF XY: 0.000247 AC XY: 88AN XY: 356964
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000464 AC: 7AN: 150880Hom.: 0 Cov.: 27 AF XY: 0.0000679 AC XY: 5AN XY: 73688
ClinVar
Submissions by phenotype
Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome Pathogenic:1Uncertain:2
The observed missense c.22G>A(p.Val8Met) variant in MSTO1 gene has been reported in heterozygous state in individuals affected with mitochondrial myopathy (Gal A, et al., 2017). The p.Val8Met variant is present with 0.02% in gnomAD Exomes. This variant has been submitted to the ClinVar database as Uncertain Significance / Pathogenic. Multiple lines of computational evidences (Polyphen - Probably damaging, SIFT - Damaging and MutationTaster - Disease causing) predict a damaging effect on protein structure and function for this variant. The reference amino acid change at this position on MSTO1 gene is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Val at position 8 is changed to a Met changing protein sequence and it might alter its composition and physico-chemical properties. However, additional functional details will be required to prove the pathogenicity of this variant. For these reasons, this variant has been classified as Likely Pathogenic. -
Same nucleotide change resulting in same amino acid change has been previously reported to be associated with MSTO1 related disorder (ClinVar ID: VCV000438835, PS1_P). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000175, PM2_M). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.644, PP3_P). Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline. -
- -
not provided Uncertain:1
Reported in the heterozygous state in a family with mitochondrial myopathy, ataxia, minor dysmorphisms, endocrine dysfunctions, and psychiatric symptoms (Gal et al., 2017); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 34426522, 33672784, 30684668, 29339779, 31604776, 36468072, 33222031, 28554942) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at